These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 2448461)

  • 41. Antiserum against Escherichia coli J5 contains antibodies reactive with outer membrane proteins of heterologous gram-negative bacteria.
    Hellman J; Zanzot EM; Loiselle PM; Amato SF; Black KM; Ge Y; Kurnick JT; Warren HS
    J Infect Dis; 1997 Nov; 176(5):1260-8. PubMed ID: 9359727
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protective capacity of antibodies against Escherichia coli and K antigens.
    Kaijser B; Ahlstedt S
    Infect Immun; 1977 Aug; 17(2):286-9. PubMed ID: 70410
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The porin protein of the outer membrane of Escherichia coli: reactivity in immunoblotting, antibody-binding by the native protein, and cross-reactivity with other enteric bacteria.
    Henriksen AZ; Maeland JA
    Acta Pathol Microbiol Immunol Scand B; 1987 Oct; 95(5):315-21. PubMed ID: 2445170
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A review: relation between invasiveness and the K1 capsular polysaccharide of Escherichia coli.
    Schiffer MS; Oliveira E; Glode MP; McCracken GH; Sarff LM; Robbins JB
    Pediatr Res; 1976 Feb; 10(2):82-7. PubMed ID: 1107953
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Protection against Salmonella typhi infection in mice after immunization with outer membrane proteins isolated from Salmonella typhi 9,12,d, Vi.
    Isibasi A; Ortiz V; Vargas M; Paniagua J; González C; Moreno J; Kumate J
    Infect Immun; 1988 Nov; 56(11):2953-9. PubMed ID: 2844676
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Granulocyte colony-stimulating factor enhances protection by anti-K1 capsular IgM antibody in murine Escherichia coli sepsis.
    Hustinx W; Benaissa-Trouw B; Van Kessel K; Kuenen J; Tavares L; Kraaijeveld K; Verhoef J; Hoepelman A
    Eur J Clin Invest; 1997 Dec; 27(12):1044-8. PubMed ID: 9466134
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunotherapy of gram-negative bacterial sepsis: enhanced survival in a guinea pig model by use of rabbit antiserum to Escherichia coli J5.
    Dunn DL; Ferguson RM
    Surgery; 1982 Aug; 92(2):212-9. PubMed ID: 7048594
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Murine monoclonal antibody elicited with antibiotic-exposed Escherichia coli exerts protective capacity in experimental bacterial infections.
    Lun MT; Amatucci AM; Raponi G; Filadoro F; Bartolazzi A; Fraioli R; Natali PG; Mancini C
    J Med Microbiol; 1994 Sep; 41(3):179-83. PubMed ID: 8064837
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cross-reactive antibody in immunity to colisepticemia in calves.
    Wickstrom ML; Gay CC; Hodgson JL; Widders PR; Schaeffer D; Lee R; Corbeil LB
    Vet Microbiol; 1987 Mar; 13(3):259-71. PubMed ID: 3310376
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antiserum against Escherichia coli J5: a re-evaluation of its in vitro and in vivo activity against heterologous gram-negative bacteria.
    Trautmann M; Hahn H
    Infection; 1985; 13(3):140-5. PubMed ID: 3897069
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli.
    Lasaro MO; Luiz WB; Sbrogio-Almeida ME; Ferreira LC
    Vaccine; 2005 Mar; 23(19):2430-8. PubMed ID: 15752829
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of Escherichia coli K1 colominic acid-specific murine antibodies that are cross-protective against Neisseria meningitidis groups B, C, and Y.
    Park IH; Lin J; Choi JE; Shin JS
    Mol Immunol; 2014 Jun; 59(2):142-53. PubMed ID: 24603121
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Release of gram-negative outer-membrane proteins into human serum and septic rat blood and their interactions with immunoglobulin in antiserum to Escherichia coli J5.
    Hellman J; Loiselle PM; Zanzot EM; Allaire JE; Tehan MM; Boyle LA; Kurnick JT; Warren HS
    J Infect Dis; 2000 Mar; 181(3):1034-43. PubMed ID: 10720528
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protection against enteric septicemia of catfish (Ictalurus punctatus) by immunization with the R-mutant, Escherichia coli (J5).
    Tyler JW; Klesius PH
    Am J Vet Res; 1994 Sep; 55(9):1256-60. PubMed ID: 7802393
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acquisition of genes from an O18:K1:H7 ColV+ strain of Escherichia coli renders intracranially-inoculated E. coli K12 highly virulent for chickens, ducks and guinea-pigs but not mice.
    Smith HW; Huggins MB
    J Hyg (Lond); 1985 Oct; 95(2):363-74. PubMed ID: 3905956
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum antibodies to outer membrane proteins of Escherichia coli in healthy persons and patients with bacteremia.
    Henriksen AZ; Maeland JA
    J Clin Microbiol; 1987 Nov; 25(11):2181-8. PubMed ID: 3320085
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antibody responses to Escherichia coli J5 lipopolysaccharide and to Salmonella porin in patients with bacteremia.
    Brauner A; Källenius G; Wrangsell G; Wretlind B; Svenson SB
    Microb Pathog; 1986 Oct; 1(5):475-81. PubMed ID: 2854603
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Outer membrane protein A (OmpA), peptidoglycan-associated lipoprotein (PAL), and murein lipoprotein (MLP) are released in experimental Gram-negative sepsis.
    Hellman J; Warren HS
    J Endotoxin Res; 2001; 7(1):69-72. PubMed ID: 11521086
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Active immunization with a detoxified Escherichia coli J5 lipopolysaccharide group B meningococcal outer membrane protein complex vaccine protects animals from experimental sepsis.
    Cross AS; Opal SM; Warren HS; Palardy JE; Glaser K; Parejo NA; Bhattacharjee AK
    J Infect Dis; 2001 Apr; 183(7):1079-86. PubMed ID: 11237833
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Employing Escherichia coli-derived outer membrane vesicles as an antigen delivery platform elicits protective immunity against Acinetobacter baumannii infection.
    Huang W; Wang S; Yao Y; Xia Y; Yang X; Li K; Sun P; Liu C; Sun W; Bai H; Chu X; Li Y; Ma Y
    Sci Rep; 2016 Nov; 6():37242. PubMed ID: 27849050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.